| Product Code: ETC7538339 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India bipolar disorder therapeutics market import shipment demonstrated a remarkable CAGR from 2020 to 2024. Notably, the growth rate surged between 2023 and 2024, indicating accelerating momentum. The market expanded significantly over the analyzed period, showing a strong upward trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Bipolar Disorder Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Bipolar Disorder Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Bipolar Disorder Therapeutics Market - Industry Life Cycle |
3.4 India Bipolar Disorder Therapeutics Market - Porter's Five Forces |
3.5 India Bipolar Disorder Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Bipolar Disorder Therapeutics Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
4 India Bipolar Disorder Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about mental health disorders in India |
4.2.2 Rising prevalence of bipolar disorder cases in India |
4.2.3 Growing acceptance and availability of treatment options for bipolar disorder patients |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders in India |
4.3.2 Limited access to specialized healthcare services in certain regions of India |
4.3.3 High cost of bipolar disorder therapeutics and treatment |
5 India Bipolar Disorder Therapeutics Market Trends |
6 India Bipolar Disorder Therapeutics Market, By Types |
6.1 India Bipolar Disorder Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Mood Stabilizers, 2021- 2031F |
6.1.4 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Antipsychotic Drugs, 2021- 2031F |
6.1.5 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Antidepressant Drugs, 2021- 2031F |
6.1.6 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 India Bipolar Disorder Therapeutics Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.3 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Serotonin-norepinephrine Reuptake Inhibitors, 2021- 2031F |
6.2.4 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Tricyclic Antidepressants, 2021- 2031F |
6.2.5 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Monoamine Oxidase Inhibitors, 2021- 2031F |
6.2.6 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.2.7 India Bipolar Disorder Therapeutics Market Revenues & Volume, By Beta Blockers, 2021- 2031F |
7 India Bipolar Disorder Therapeutics Market Import-Export Trade Statistics |
7.1 India Bipolar Disorder Therapeutics Market Export to Major Countries |
7.2 India Bipolar Disorder Therapeutics Market Imports from Major Countries |
8 India Bipolar Disorder Therapeutics Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted in India |
8.2 Percentage increase in diagnosed cases of bipolar disorder annually |
8.3 Adoption rate of new therapeutic options for bipolar disorder in India |
9 India Bipolar Disorder Therapeutics Market - Opportunity Assessment |
9.1 India Bipolar Disorder Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Bipolar Disorder Therapeutics Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
10 India Bipolar Disorder Therapeutics Market - Competitive Landscape |
10.1 India Bipolar Disorder Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Bipolar Disorder Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here